Pulling Back the Curtain: Roy Silverstein, MD – ASH Clinical News
Pulling Back the Curtain: Roy Silverstein, MD – Pulling Back the Curtain – ASH Clinical News
Related Articles
Abelacimab Demonstrates Safety, Superior Bleeding Reduction Compared With Rivaroxaban in Atrial Fibrillation | ASH Clinical News | American Society of Hematology
Khylia Marshall is a freelance journalist based in Tucson, Arizona. Patients with atrial fibrillation (AF) face an increased risk of stroke, yet many remain undertreated…
DNMT3A Mutations Found in Frequent Blood Donors, But No Clonal Hematopoiesis Increase | ASH Clinical News | American Society of Hematology
Katie Robinson is a medical writer based in New York. For older male blood donors with a history of extensive donation, the frequency of clonal…
Practical Solutions to Promoting Scholarly Output in Hematology Amid Cuts to Federally Funded Research | ASH Clinical News | American Society of Hematology
In this Letter to the Editor, Shyam A. Patel, MD, PhD, discusses the dependence academic institutions have on federal funding for research and where investigators…
May 2025 | ASH Clinical News | American Society of Hematology
May 2025 | ASH Clinical News | American Society of Hematology May 2025 An Endangered Endeavor? For hematologic malignancies, cooperative clinical trials are just as…
Final CAVEAT Results Further Support Venetoclax Plus Intensive Chemotherapy in Older Patients With AML | ASH Clinical News | American Society of Hematology
Leah Lawrence is a freelance health writer and editor based in Delaware. The combination regimen of venetoclax plus modified intensive chemotherapy had an acceptable side…
Study Suggests Disparities in MM Outcomes Persist on a Global Scale | ASH Clinical News | American Society of Hematology
Khylia Marshall is a freelance journalist based in Tucson, Arizona. Previous studies have revealed disparities in the prevalence, management, and outcomes of multiple myeloma (MM)…
ASH Clinical News: May 2025 From the Desk Of…
Editor-in-Chief Aaron Gerds, MD, previews what’s to come in the next issue of ASH Clinical News. Highlights of the May issue include a feature article…
FDA Approves R/R LBCL Treatment | ASH Clinical News | American Society of Hematology
The U.S. Food and Drug Administration (FDA) approved brentuximab vedotin (BV) in combination with lenalidomide and rituximab to treat relapsed or refractory (R/R) large B-cell…
BCMA CAR T Cells Effective, Safe for Older Adults and Frail Patients with R/R Multiple Myeloma | ASH Clinical News | American Society of Hematology
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. Although chimeric antigen receptor (CAR) T-cell therapies have transformed the care of relapsed…
SACRED Trial Shows Utility of Hydroxyurea for Stroke Prevention in Hispanic Children with SCA | ASH Clinical News | American Society of Hematology
Ruth Jessen Hickman, MD, is a freelance medical and science writer based in Bloomington, Indiana. The Hispanic Caribbean island of the Dominican Republic (DR) has…